High molecular weight insulin-like growth factor binding protein complex
If a solution changes color, develops an odor, or shows visible particles, discard it and prepare fresh
The Substances on the Table These are the drugs being reviewed and the medical uses FDA will be evaluating: July 23, 2026: BPC-157 (free base and acetate) ulcerative colitis KPV (free base and acetate) wound healing and inflammatory conditions TB-500 (free base and acetate) wound healing MOTs-C (free base and acetate) obesity and osteoporosis July 24, 2026: Emideltide / DSIP (delta sleep-inducing peptide, free base and acetate) opioid withdrawal, chronic insomnia, and narcolepsy Semax (free base and acetate) cerebral ischemia, migraine, and trigeminal neuralgia Epitalon (free base and acetate) insomnia If any or all of these substances are added to the 503A Bulks List following this process, it would formalize the legal pathway for licensed pharmacists and physicians to compound them for patients
I prefer a nurse as my injector and appreciate her experience
Documented consent that reflects the products unlicensed status, a clear aftercare record, and a plan for what happens if a complication arises are not optional extras for a product sitting in this regulatory space theyre the minimum that protects both patient and practitioner
